364 results
Page 5 of 19
8-K
EX-99.1
0euus1mij86
6 Feb 20
Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results for 2019
8:20am
8-K
EX-99.1
fhxgbwu5pt817
20 Nov 19
Creating a Leading Biopharma Company
5:21pm
425
EX-99.1
v7km8fpycglqz 0vv
15 Nov 19
Business combination disclosure
5:20pm
8-K
EX-99.1
7qnssun5u56yaq
15 Nov 19
Bristol-Myers Squibb Receives Clearance from U.S. Federal Trade Commission for Celgene Acquisition
5:20pm
8-K
EX-99.1
tukx2c35my b2ugr
31 Oct 19
Bristol-Myers Squibb Reports Third Quarter Financial Results
8:01am
8-K
EX-99.1
cz57sj4dbjkcr7
12 Sep 19
Bristol-Myers Squibb Board Announces Election of Three New Directors
5:27pm
8-K
EX-99.1
lvj7 l6loet
26 Aug 19
Bristol-Myers Squibb Announces Agreement Between Celgene and Amgen to Divest OTEZLA® for $13.4 Billion
8:30am
8-K
EX-99.1
ujbvbf
25 Jul 19
Bristol-Myers Squibb Reports Second Quarter Financial Results
8:21am
8-K
EX-99.1
ar0 35xnty
1 Jul 19
Bristol-Myers Squibb Completes Divestment of UPSA
6:59am
8-K
EX-99.1
79dr23ob3n9djant4
24 Jun 19
Bristol-Myers Squibb Provides Update on Pending Merger with Celgene
8:01am
8-K
EX-99.1
8ep k15pvl
5 Jun 19
Bristol-Myers Squibb Announces Post-Closing Leadership Team
8:24am
8-K
EX-99.1
kus0t2koa kpf
8 May 19
Other Events
5:02pm
8-K
EX-99.2
pwhcn
1 May 19
Regulation FD Disclosure
5:24pm
8-K
EX-99.1
urvflem
25 Apr 19
Bristol-Myers Squibb Reports First Quarter Financial Results
8:05am
8-K
EX-99.1
qevltpr a9
12 Apr 19
Bristol-Myers Squibb Shareholders Approve Celgene Acquisition
5:27pm
425
EX-99.1
79jkw v8h5kluvhury
12 Apr 19
Business combination disclosure
5:25pm